drugset / Trial / NCT00600847

A Study to Assess and Compare the Effects of 5 mg vs. 20 mg Desloratadine on the Development of Cold Urticaria Lesions

NCT00600847

Phase 4 Completed 33 enrolled Charite University, Berlin, Germany
RandomizedCrossoverTriple-blindTreatment

Summary

The aim of this study is to compare cold urticaria lesions by thermography, volumetry and digital time lapse photography in ACU patients treated with placebo, 5 mg and 20 mg desloratadine. Hypothesis: The updosing of desloratadine (20 mg)is more effective in the treatment of ACU symptoms as compared to standard doses (5 mg desloratadine) and placebo.

Timeline

Start
2006-11
Primary completion
2007-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desloratadine Small molecule 5 mg Oral
Comparator Desloratadine Small molecule 20 mg Oral

Indications